BioSpace News Archive

PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations, announced the appointment of Kirsten Flowers to its Board of Directors.

HCW Biologics Inc., a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic, low-grade inflammation and age-related diseases, announced that members of the HCW Biologics management team will participate in the H.C. Wainwright BioConnect Conference.

Soligenix, Inc. announced that the Company will deliver a corporate presentation at the upcoming virtual investor conferences below.

Apnimed to Present at the 40th Annual JP Morgan Healthcare Conference.

Alnylam Pharmaceuticals, Inc. today announced a collaboration with Novartis to leverage Alnylam’s proven, proprietary siRNA technology.

Aptinyx Inc. today provided a corporate update and highlighted development milestones anticipated in 2022.

Arch Therapeutics, Inc. today announced a study of its proprietary adaptive self-assembling barrier scaffold (aSABS) and peptide technology, AC5 ® Advanced Wound System.

Galectin Therapeutics Inc., the leading developer of therapeutics that target galectin proteins, announced the Company will be participating in the H.C. Wainwright BioConnect Conference being held virtually January 10-13, 2022.

ProMIS Neurosciences, Inc. announced its participation in the H.C. Wainwright BioConnect 2022 Virtual Conference being held January 10–13, 2022.

Gennao Bio today announced the appointments of Joseph W. McIntosh, M.D., as chief medical officer, and Anuj Goswami, J.D., MBA, as general counsel.